BayBiotek is dedicated to Biotechnology and Pharmaceutical professionals to keep them informed with the latest updates and innovations in the field. We are pledged to the partners for their professional growth and success through our over 10 years of experience in this field. We are continuously monitoring the most important information sources in the field of drug development, clinical research and life sciences in general.

 Drugs in the News July 31^st, 2006

• Abbott Laboratories, Illinois announced the approval of HUMIRA for treating ankylosing spondylitis. HUMIRA also is approved by FDA to treat rheumatoid arthritis (RA) and psoriatic arthritis (PsA).
•  Last week FDA approved Elaprase also known as Idusulfurase, to treat Hunter Syndrome, which is potentially deadly genetic disease. This is the first drug available for this disease and is made available by Shire Human Genetic Therapies of Cambridge, Massachusetts.

 Quote of the week

 “ All exact science is dominated by the idea of approximation.”

                                                                                             - Doug Larson